Signaling Pathways - MLK3 - Glucagon-like peptide 1 (GLP-1) receptors - CB2 Receptors - Insulin and Insulin-like Receptors
清除全部
- B4877 URMC-099Target: MLK3Summary: MLK3抑制剂
- B6943 Exendin-3 (9-39) amide1 CitationTarget: Glucagon-like peptide 1 (GLP-1) receptorsSummary: GLP-1受体拮抗剂
- B1425 BML-190中文名: 吲哚美辛吗啉代酰胺Target: CB2 ReceptorsSummary: CB2受体的配体
- B1429 Rimonabant3 Citation中文名: 利莫那班Target: CB1 Receptors|CB2 ReceptorsSummary: CB1 受体拮抗剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A3408 Exendin-4中文名: 艾塞那肽Target: Glucagon-like peptide 1 (GLP-1) receptorsSummary: GLP-1激活剂
- A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂,有效的胰岛素敏化剂